CNTA
Price
$28.00
Change
-$0.36 (-1.27%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
4.09B
126 days until earnings call
Intraday BUY SELL Signals
ONWRF
Price
$4.77
Change
-$0.38 (-7.38%)
Updated
Nov 14 closing price
Capitalization
269.38M
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTA vs ONWRF

Header iconCNTA vs ONWRF Comparison
Open Charts CNTA vs ONWRFBanner chart's image
Centessa Pharmaceuticals
Price$28.00
Change-$0.36 (-1.27%)
Volume$35.58K
Capitalization4.09B
Onward Med
Price$4.77
Change-$0.38 (-7.38%)
Volume$2.8K
Capitalization269.38M
CNTA vs ONWRF Comparison Chart in %
CNTA
Daily Signal:
Gain/Loss:
ONWRF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTA vs. ONWRF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Hold and ONWRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (CNTA: $28.36 vs. ONWRF: $4.77)
Brand notoriety: CNTA and ONWRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 147% vs. ONWRF: 331%
Market capitalization -- CNTA: $4.09B vs. ONWRF: $269.38M
CNTA [@Biotechnology] is valued at $4.09B. ONWRF’s [@Biotechnology] market capitalization is $269.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileONWRF’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • ONWRF’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than ONWRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 4 TA indicator(s) are bullish while ONWRF’s TA Score has 4 bullish TA indicator(s).

  • CNTA’s TA Score: 4 bullish, 4 bearish.
  • ONWRF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ONWRF is a better buy in the short-term than CNTA.

Price Growth

CNTA (@Biotechnology) experienced а +25.82% price change this week, while ONWRF (@Biotechnology) price change was +7.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

CNTA is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($4.09B) has a higher market cap than ONWRF($269M). CNTA YTD gains are higher at: 67.164 vs. ONWRF (-20.500). ONWRF has higher annual earnings (EBITDA): -34.06M vs. CNTA (-214.83M). CNTA has more cash in the bank: 251M vs. ONWRF (40.9M). ONWRF has less debt than CNTA: ONWRF (15.1M) vs CNTA (118M). CNTA has higher revenues than ONWRF: CNTA (15M) vs ONWRF (1.26M).
CNTAONWRFCNTA / ONWRF
Capitalization4.09B269M1,520%
EBITDA-214.83M-34.06M631%
Gain YTD67.164-20.500-328%
P/E RatioN/AN/A-
Revenue15M1.26M1,187%
Total Cash251M40.9M614%
Total Debt118M15.1M781%
TECHNICAL ANALYSIS
Technical Analysis
CNTAONWRF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
36%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
36%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
83%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
25%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signal:
Gain/Loss:
ONWRF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLQIX16.710.08
+0.48%
BNY Mellon Large Cap Equity I
SPGIX45.92N/A
N/A
SEI Large Cap Growth I (SIMT)
COSSX14.32N/A
N/A
Columbia Overseas Value Inst2
SMYSX28.80N/A
N/A
Franklin Global Equity IS
RALIX10.82-0.07
-0.64%
Lazard Real Assets Instl

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with CLDX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-1.27%
CLDX - CNTA
43%
Loosely correlated
-2.58%
ROIV - CNTA
42%
Loosely correlated
-0.88%
RVMD - CNTA
40%
Loosely correlated
-0.04%
VRDN - CNTA
38%
Loosely correlated
+0.31%
NUVL - CNTA
38%
Loosely correlated
+2.71%
More

ONWRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONWRF has been loosely correlated with SHJBF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ONWRF jumps, then SHJBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONWRF
1D Price
Change %
ONWRF100%
N/A
SHJBF - ONWRF
42%
Loosely correlated
N/A
CNTA - ONWRF
24%
Poorly correlated
-1.27%
UCBJF - ONWRF
23%
Poorly correlated
N/A
INO - ONWRF
22%
Poorly correlated
-5.82%
ACUT - ONWRF
8%
Poorly correlated
+3.16%
More